Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ripeta is a technology company that develops software solutions to assess and improve the reproducibility and integrity of scientific research. The company's platform utilizes natural language processing and machine learning to scan research manuscripts for "trust markers," such as data sharing statements, code availability, and ethical declarations. By automating the evaluation of research transparency, Ripeta serves academic publishers, funding agencies, and research institutions in their efforts to uphold high scientific standards. Founded in 2017 and acquired by Digital Science in 2021, the company plays a critical role in addressing the reproducibility crisis within the life sciences and broader scholarly community. Their tools, such as RipetaReview, provide actionable insights that help stakeholders ensure that published research is both verifiable and robust.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ripeta.